Asthma can block airways, making it hard to breathe, and in severe cases can cause death if not treated quickly.

The pharmaceutical industry stands at a crossroads where innovations in treatment sometimes conflict with patient realities.

From raising compliance concerns to inaccurate targeting, third-party data could be holding your POC strategy back. Here's why you need to switch to first-party partners.

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more. In a world where healthcare is moving fast, HCG is moving faster. Always ahead of the ...

WPP’s chief executive spoke at SWSW and touched on hybrid working, the future of the workforce with AI and whether brands ...

By registering you consent to the collection and use of your information to provide the products and services you have ...

Experts who reviewed the code for ProPublica found numerous and troubling flaws in the system, providing a disturbing glimpse ...

The first shortlists revealed for 2025 are for the Dan Wieden Titanium Lions and Innovation Lions categories. Cannes Lions ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

Experts who reviewed the code for ProPublica found numerous and troubling flaws in the system, providing a disturbing glimpse into how the Trump administration is allowing artificial intelligence to ...

WPP has launched data service Open Intelligence, which it is calling the advertising industry’s “first large marketing model.